Richiedi una copia del documento: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114) : an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group

Captcha code
Annulla